It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Small nucleolar RNA host gene 17 (SNHG17), a novel functional long noncoding RNA, has been demonstrated to play an essential role in the oncogenesis of several tumors. However, for esophageal squamous cell carcinoma (ESCC) the expression pattern and detailed function of SNHG17 are largely unknown. Hence, we conducted this study to explore potential roles and underlying oncogenic mechanisms for SNHG17 in ESCC progression. Results demonstrated SNHG17 to be markedly upregulated in ESCC. Knockdown of SNHG17 significantly suppressed ESCC cell proliferation, invasion, and epithelial–mesenchymal transition in vitro and tumor growth in vivo. Online database software analysis found miR-338-3p to interact with SNHG17 with the level of miR-338-3p negatively correlated with SNHG17 levels in ESCC samples. Further, miR-338-3p was found to directly target SRY-box transcription factor 4 (SOX4) in ESCC cells. Mechanistic analysis suggested that SNHG17 acts as an endogenous “sponge” competing with miR-338-3p to regulate SOX4, thereby promoting tumor progression. These results suggest that these molecular interactions may be potential therapeutic targets for ESCC.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details




1 Xi’an Jiaotong University Health Science Center, Department of Cell Biology and Genetics, School of Basic Medical Sciences, Xi’an, China (GRID:grid.43169.39) (ISNI:0000 0001 0599 1243); Hangzhou Medical College, School of Basic Medical Sciences & Forensic Medicine, Hangzhou, China (GRID:grid.506977.a)
2 Hangzhou Medical College, School of Basic Medical Sciences & Forensic Medicine, Hangzhou, China (GRID:grid.506977.a)
3 Xi’an Jiaotong University Health Science Center, Department of Pathology, School of Basic Medical Sciences, Xi’an, China (GRID:grid.43169.39) (ISNI:0000 0001 0599 1243)
4 Zhejiang Cancer Hospital, Department of Ward Pharmacy, Hangzhou, China (GRID:grid.417397.f) (ISNI:0000 0004 1808 0985)
5 Zhejiang Cancer Hospital, Department of Thoracic surgery, Hangzhou, China (GRID:grid.417397.f) (ISNI:0000 0004 1808 0985)
6 Xi’an Jiaotong University Health Science Center, Department of Cell Biology and Genetics, School of Basic Medical Sciences, Xi’an, China (GRID:grid.43169.39) (ISNI:0000 0001 0599 1243); Xi’an Jiaotong University Health Science Center, Key Laboratory of Environment and Genes Related to Diseases, Xi’an, China (GRID:grid.43169.39) (ISNI:0000 0001 0599 1243)